Brief: OptimizeRx Continues To Expand Its Strategic Relationship With Top-Tier Pharma Client
10/09/2024 13:03
Sept 10 (Reuters) - OPTIMIZERx Corp OPRX.O :
* OPTIMIZERX CONTINUES TO EXPAND ITS STRATEGIC RELATIONSHIP
WITH A
TOP-TIER PHARMA CLIENT VIA A MULTI-BRAND, MULTI-SOLUTION
INVESTMENT COMMITMENT WITH OVER $10M IN-YEAR TOTAL VALUE
Source text for Eikon: ID:nGNX8qDvqs
Further company coverage: OPRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on OptimizeRx
See all newsBrief: Optimizerx Announces Finance Leadership Appointments To Support The Next Phase Of Growth
OptimizeRx Corporation reports results for the quarter ended June 30 - Earnings Summary
OptimizeRx Q2 revenue beats estimates on operating resilience; reaffirms outlook
OptimizeRx Corporation expected to post earnings of 12 cents a share - Earnings Preview
Brief: Optimizerx Corp - Enters Credit Agreement With Fifth Third Bank On May 7, 2026 - SEC Filing